Dr Siv was great with diagnosis of my double visions. I can see better now w adjusted prescriptions. Front office staff was wonderful!
— Terri Nguyen
HZO often gives early warning signs before the rash appears, and eye-related symptoms can develop days or even weeks after the skin heals. Knowing what to look for at every stage helps you act quickly.
A few days before the rash, many people feel pain, burning, or tingling on one side of the forehead or around the eye. The skin may feel unusually sensitive to touch. Some people also develop a headache, mild fever, or fatigue during this early phase. Because these symptoms can look like a common viral illness, HZO is sometimes missed at this stage.
The rash begins as red patches that quickly become clusters of small blisters. It follows one side of the forehead, the upper eyelid, and sometimes the nose. The rash stays on one side of the face and does not cross the midline. Over several days, the blisters crust over and begin to heal. The pattern of the rash, confined to one side and following the nerve path, is usually distinctive enough for a trained eye to recognize immediately.
Hutchinson sign refers to blisters on the tip or side of the nose. This is an important warning because the same small nerve branch that reaches the nose also connects to the eye. When Hutchinson sign is present, the risk of corneal inflammation, iritis (inflammation inside the front of the eye), and other eye problems increases significantly. Anyone with blisters on the nose during a shingles outbreak needs a prompt eye examination.
Eye-related symptoms can include redness, tearing, pain, blurred vision, and sensitivity to light. Some people also notice a gritty or scratchy sensation, or find it difficult to fully open the eye because of swelling in the eyelid. In more serious cases, the cornea can become cloudy. These symptoms may appear alongside the rash or emerge weeks after the skin has healed, so ongoing watchfulness is important.
Postherpetic neuralgia is a complication of shingles in which burning or stabbing nerve pain persists for more than 90 days after the rash first appeared. Older age is the strongest predictor of developing this complication. The pain can be severe enough to affect sleep, mood, and daily activities. It often requires ongoing management from both an eye care provider and a pain specialist.
The virus can affect multiple structures within and around the eye, and some complications appear long after the initial rash has cleared. Understanding the range of possible eye conditions helps explain why follow-up care continues well beyond the active outbreak.
Early HZO often involves the eyelid margin and the outer surface of the eye. Blepharitis (inflammation along the edge of the eyelid) and conjunctivitis (redness and irritation of the clear tissue lining the eye) are both common. Blisters on the eyelid can leave small scars along the lid margin. Most surface problems improve as the rash heals, but lubricating drops and lid hygiene are often needed for several weeks.
The cornea can be affected in several distinct ways. Early in the infection, small branching sores called dendrites can form on the corneal surface. Later, deeper inflammation can create cloudy patches within the corneal tissue. A separate pattern of inflammation called disciform keratitis can develop weeks or even months after the rash, presenting as a disc-shaped area of swelling in the cornea that requires careful management with steroid drops.
HZO can permanently reduce the sensitivity of the corneal nerves. When those nerves are damaged, the eye loses its ability to detect dryness or minor injury, a condition called neurotrophic keratopathy. Without that protective feedback, the surface of the cornea can break down without causing the usual warning pain. This type of damage can appear months after the original outbreak and requires close, long-term follow-up.
Iritis, also called anterior uveitis, is inflammation inside the front chamber of the eye. It causes a deep aching pain, redness, and light sensitivity. HZO can also inflame the eye's internal drainage structures, which raises the pressure inside the eye. If elevated eye pressure is not treated promptly, it can damage the optic nerve, the cable that sends visual information to the brain.
In rare but serious cases, the virus can reach the back of the eye. Acute retinal necrosis is a rapidly progressing form of retinal inflammation that can cause sudden blurred vision, new floaters, and significant vision loss. HZO can also weaken the nerves that control eye movement, which leads to double vision. Any new floaters, flashes, or sudden vision change during or after an HZO episode should be treated as an urgent matter.
Diagnosis usually begins with a clinical examination, but several additional checks are part of a thorough evaluation. The goal is not only to confirm the diagnosis but also to find any eye complications that may not yet be causing noticeable symptoms.
In most cases, the characteristic one-sided rash combined with a complete eye exam is enough to make the diagnosis. The exam evaluates the eyelids, corneal surface, iris, internal eye structures, eye pressure, and the back of the eye. Our Cornea Specialist uses slit-lamp magnification to examine the cornea in detail and look for the specific patterns of inflammation that HZO is known to cause.
Testing how well the cornea responds to gentle touch helps identify nerve damage. A reduced or absent response is a sign of neurotrophic disease and signals the need for more frequent follow-up visits and proactive use of lubricating drops to protect the corneal surface.
Eye pressure is measured at every visit because HZO-related pressure elevation can develop silently, without any noticeable discomfort. Regular pressure checks during and after an HZO episode are essential. Some patients require pressure-lowering eye drops for weeks or months until the inflammation settles.
A dilated eye exam, in which drops are used to widen the pupil for a fuller view of the back of the eye, is used to check for retinal inflammation or other serious back-of-eye complications. Any sudden change in vision, new floaters, or light flashes in someone with known HZO is treated as urgent and warrants a same-day retina exam.
Lab testing is not required in typical presentations. When the rash is mild, absent, or atypical, PCR testing of blister fluid or eye surface samples can confirm the virus with high accuracy. PCR testing is also used when deeper eye inflammation has an unclear cause and the clinical picture alone is not sufficient for diagnosis.
Treatment for HZO addresses the active virus, the inflammation it causes inside the eye, and any longer-term complications that develop. The specific combination of treatments depends on which structures of the eye are affected and how far along the infection is.
Oral antiviral pills are the foundation of HZO treatment. Common options include acyclovir, valacyclovir, and famciclovir, each taken for approximately seven days. Starting treatment within 72 hours of the rash appearing produces the greatest benefit: a shorter active phase, a lower risk of eye complications, and a reduced chance of developing long-term nerve pain. Even if the 72-hour window has passed, starting antivirals is still recommended and can still be helpful.
Steroid eye drops are used to treat stromal keratitis (deep corneal inflammation), iritis, and immune-related inflammation in the eye. A gradual taper over several weeks is typical, because stopping too quickly can allow inflammation to rebound. Lubricating drops and gentle lid care help protect the ocular surface while it heals. In selected cases, topical antiviral drops or gel are used for active viral disease on the corneal surface.
When eye pressure rises due to HZO-related inflammation, pressure-lowering eye drops are prescribed to protect the optic nerve. In most patients, the pressure elevation is temporary and the drops can be tapered once inflammation is controlled. Regular pressure checks guide that process, so treatment is stopped safely rather than too soon.
Postherpetic neuralgia often does not respond well to standard over-the-counter pain relievers. Oral medications that target nerve pain, such as gabapentin and certain tricyclic antidepressants used at low doses, are frequently helpful. Topical patches containing lidocaine or capsaicin can provide additional relief. A pain specialist may need to be involved when pain is severe or not responding to initial treatment. Starting antivirals early remains the single best way to reduce the risk of this complication.
Some patients experience repeated flares of HZO-related corneal inflammation or iritis long after the initial outbreak. For this group, a course of daily low-dose antiviral medication, most often valacyclovir, may be recommended on an ongoing basis to reduce the frequency of recurrences. This approach is supported by evidence from large clinical research studies. Our Cornea Specialist can help determine whether suppressive therapy is appropriate for your situation.
When corneal damage is extensive or long-standing, additional interventions may be needed beyond drops alone. A bandage contact lens can shield a fragile corneal surface. Amniotic membrane grafts can support healing in stubborn surface defects. Severe corneal scarring that obstructs vision may ultimately require surgical treatment. These options are reserved for the most advanced cases and are always considered after the active viral phase has been controlled.
Vaccination is the most effective tool available for reducing the risk of shingles and its eye complications. Additional steps can support your immune system's ability to keep the virus in check over the long term.
The recombinant shingles vaccine is recommended by the CDC for adults aged 50 and older, and for adults aged 19 and older who have a weakened immune system. It is given as two doses separated by two to six months. In the years following vaccination, reported effectiveness against developing shingles and its complications runs at approximately 90 percent. The vaccine does not contain live virus and is generally well tolerated.
By lowering the overall risk of shingles, vaccination directly reduces your chances of ever developing HZO. When shingles does occur in vaccinated individuals, the illness tends to be milder. That translates to a meaningfully lower risk of corneal scarring, iritis, elevated eye pressure, and postherpetic neuralgia. For older adults and anyone with a condition that affects immune function, the shingles vaccine is one of the clearest preventive steps available for long-term eye health.
Beyond vaccination, general immune health plays a role in keeping the virus dormant. Consistent sleep, balanced nutrition, and steady management of ongoing medical conditions all contribute. People who take immune-suppressing medications should speak with their primary care provider and relevant specialists about the best timing for vaccination, since timing matters for effectiveness and safety.
HZO itself cannot spread from one person to another as shingles. However, the fluid inside active blisters contains live virus that can cause chickenpox in someone who has never had it and has not been vaccinated. While blisters are open and active, keep them covered. Avoid close contact with newborns, pregnant individuals who have never had chickenpox, and people with weakened immune systems until every blister has fully crusted over.
Most people who receive prompt antiviral treatment do well, but HZO is a condition that deserves ongoing attention. Eye complications can appear or return well after the rash has healed, which is why continued follow-up visits are a central part of good HZO care.
The skin rash typically crusts over within one to two weeks. Acute pain and viral activity usually settle within a few weeks after that. Eye complications, however, can develop on a delayed timeline, sometimes emerging weeks or months after the skin appears fully healed. This is why the end of the visible rash does not mean the end of the eye care plan.
With early treatment, most people return to their baseline vision or close to it. Some patients experience lasting effects including corneal scarring, reduced corneal nerve sensitivity, or recurrent iritis that can affect vision over time. Consistent eye care, attention to corneal surface health, and prompt treatment of any recurrences help limit those long-term effects. A small number of patients with significant corneal damage may require more advanced intervention to restore functional vision.
Contact an eye care provider the same day if you notice a one-sided blistering rash on the forehead, upper eyelid, or nose, particularly if it is accompanied by eye pain, redness, blurred vision, or light sensitivity. Urgent evaluation is also warranted for any sudden vision loss, new floaters, or flashes during or after an HZO episode, as these can signal serious involvement at the back of the eye. Acting quickly gives antiviral medication the best chance of working effectively.
Regular eye exams for several months following an HZO episode allow your care team to monitor the cornea, iris, and eye pressure, and to check for signs of neurotrophic nerve damage. Patients with a history of eye complications related to HZO may benefit from extended follow-up over a period of years, since inflammation and surface problems can recur even after a long quiet period. Staying engaged with your eye care is the most reliable safeguard against long-term vision loss.
These answers address common questions that go beyond what is covered in the sections above, including guidance on day-to-day decisions and when to act quickly.
A full repeat outbreak in the same nerve region is less common than a first episode but is possible. More often, patients experience recurrent flares of corneal inflammation or iritis that are linked to the original HZO, sometimes appearing months or years after the initial rash has gone. These flares may occur with no new skin rash at all, which is why any new eye pain, redness, or light sensitivity in someone with a history of HZO warrants a prompt exam rather than a wait-and-see approach.
That depends entirely on the degree of eye involvement. Blurred vision, significant light sensitivity, or severe eye pain can make driving unsafe. Many patients find it necessary to take a few days away from driving during the worst of the acute phase. The safest approach is to ask for a specific recommendation at your exam, since the answer depends on the findings from that visit rather than general guidance.
Yes. Having had a previous shingles episode does not reliably protect you from a future one, and the CDC recommends the recombinant vaccine even for people who have already had shingles. The vaccine is generally given after the active episode has fully resolved, once the rash and pain have cleared. Your primary care provider can help determine the right timing for your specific situation.
Most patients complete a standard seven-day course at the time of the initial outbreak and do not need further antiviral treatment. However, patients who experience repeated corneal inflammation or iritis flares after their HZO episode may be candidates for ongoing low-dose suppressive therapy. That decision is made on an individual basis, weighing the frequency and severity of recurrences against the benefits and considerations of long-term medication use.
Eye makeup should be avoided until the rash has fully crusted over and the skin has completely healed. Applying makeup too soon can irritate already-sensitive skin and introduce bacteria to an area that is still vulnerable. When you do return to makeup use, start with fresh products and clean applicators, since any cosmetics that were in use during the active rash period may have been contaminated and should be replaced.
Air travel during the active rash phase is generally not restricted for medical reasons related to HZO itself, but the low humidity in aircraft cabins can worsen eye surface irritation and dryness, which is a concern when the cornea is already compromised. Travel should be postponed if you have been found to have retinal involvement or severe iritis, as those complications require prompt in-person monitoring. Check with your eye care provider before booking non-urgent travel until your condition is stable.
If you have a one-sided rash on your forehead, eyelid, or nose, or if you are experiencing eye pain, redness, or sudden vision changes, please reach out to us the same day. Our Cornea Specialist and clinical team in Northern Virginia are experienced in diagnosing and managing HZO at every stage, from early antiviral care to long-term follow-up for complex corneal disease. We are here to help you protect your vision and navigate every step of your recovery with expert, attentive care.